[HTML][HTML] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - Antioxidants, 2021 - mdpi.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

The 15-months clinical experience of sars-cov-2: A literature review of therapies and adjuvants

AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - ANTIOXIDANTS, 2021 - air.unimi.it
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants.

AD Inchingolo, G Dipalma, AM Inchingolo… - Antioxidants (Basel …, 2021 - europepmc.org
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

[HTML][HTML] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

AD Inchingolo, G Dipalma, AM Inchingolo… - …, 2021 - ncbi.nlm.nih.gov
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

[PDF][PDF] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants 2021, 10, 881

AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - 2021 - scienceopen.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

[PDF][PDF] The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants. Antioxidants 2021, 10, 881

AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - 2021 - core.ac.uk
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants.

AD Inchingolo, G Dipalma, AM Inchingolo… - …, 2021 - search.ebscohost.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants

AD Inchingolo, G Dipalma, AM Inchingolo… - …, 2021 - search.proquest.com
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus
responsible for the coronavirus disease of 2019 (COVID-19) that emerged in December …

The 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants.

A Inchingolo, G Dipalma, G Malcangi, L Santacroce… - 2021 - covid19.neicon.ru
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the
virus responsible for the coronavirus disease of 2019 (COVID-19) that emerged in …

[引用][C] The 15-months clinical experience of sars-cov-2: A literature review of therapies and adjuvants

AD Inchingolo, G Dipalma, AM Inchingolo, G Malcangi… - Antioxidants, 2021 - elibrary.ru